Biogen Inc.
Status: Publicly traded
Direct answer
Biogen Inc. is publicly traded on NASDAQ under the ticker BIIB.
Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative conditions. Its established portfolio includes a range of medications addressing multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy (SMA), Biogen provides SPINRAZA, while...
Can you invest in Biogen Inc.?
Yes. Biogen Inc. is publicly traded on NASDAQ under the ticker BIIB.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.